Suppr超能文献

多西他赛对LS174T细胞VEGF、bFGF和MMPs表达的抑制作用。

Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell.

作者信息

Guo Xue-Liang, Lin Geng-Jin, Zhao Hong, Gao Yong, Qian Li-Ping, Xu San-Rong, Fu Li-Na, Xu Qing, Wang Jie-Jun

机构信息

Department of Gastroenterology, Huashan Hospital, Fudan University, Shanghai 200032, China.

出版信息

World J Gastroenterol. 2003 Sep;9(9):1995-8. doi: 10.3748/wjg.v9.i9.1995.

Abstract

AIM

To study the effects of non-cytotoxic concentrations of docetaxel on some important angiogenic factors of LS174T Cells.

METHODS

The non-cytotoxic concentration of docetaxel and the activity of gelatinase were determined with MTT and gelatin zymography respectively, the expression of VEGF(vascular endothelial growth factor), bFGF (basic fibroblast growth factor), MMP (matrix metalloproteinase) 2 and MMP 9 was investigated with RT-PCR and Western blot.

RESULTS

The maximum non-cytotoxic concentration of docetaxel on LS174T Cells was 1.0 ng/ml. Compared with the solvent control group, 0.1, 0.5, 1.0 ng/ml of docetaxel could downregulate the expression of VEGF, bFGF, MMP 2 and MMP 9 and suppress the activity of gelatinase.

CONCLUSION

Our study suggests that the non-cytotoxic concentrations of docetaxel have strong antiangiogenic activity on LS174T Cells, which suggests docetaxel may be a promising antiangiogenic agent.

摘要

目的

研究非细胞毒性浓度的多西他赛对LS174T细胞某些重要血管生成因子的影响。

方法

分别采用MTT法和明胶酶谱法测定多西他赛的非细胞毒性浓度和明胶酶活性,采用RT-PCR和蛋白质印迹法检测血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)、基质金属蛋白酶(MMP)2和MMP 9的表达。

结果

多西他赛对LS174T细胞的最大非细胞毒性浓度为1.0 ng/ml。与溶剂对照组相比,0.1、0.5、1.0 ng/ml的多西他赛可下调VEGF、bFGF、MMP 2和MMP 9的表达,并抑制明胶酶活性。

结论

我们的研究表明,非细胞毒性浓度的多西他赛对LS174T细胞具有较强的抗血管生成活性,这表明多西他赛可能是一种有前景的抗血管生成药物。

相似文献

引用本文的文献

1
Evaluating the docetaxel effect in an animal model of polyarthritis.评估多关节炎动物模型中的多西紫杉醇疗效。
Inflammopharmacology. 2024 Jun;32(3):1827-1838. doi: 10.1007/s10787-024-01459-2. Epub 2024 Apr 15.
7
Targeted drug and gene delivery systems for lung cancer therapy.用于肺癌治疗的靶向药物和基因递送系统。
Clin Cancer Res. 2009 Dec 1;15(23):7299-308. doi: 10.1158/1078-0432.CCR-09-1745. Epub 2009 Nov 17.

本文引用的文献

4
The prognostic molecular markers in hepatocellular carcinoma.肝细胞癌的预后分子标志物
World J Gastroenterol. 2002 Jun;8(3):385-92. doi: 10.3748/wjg.v8.i3.385.
6
Docetaxel versus paclitaxel for antiangiogenesis.多西他赛与紫杉醇在抗血管生成方面的比较
J Hematother Stem Cell Res. 2002 Feb;11(1):103-18. doi: 10.1089/152581602753448577.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验